Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy
Publication status
publishedExternal links
Journal / series
Cellular SignallingVolume
Pages / Article No.
Publisher
ElsevierSubject
MNK; eIF4E; eIF4G; Glioma; MTC; TemozolomideOrganisational unit
03688 - Schibli, Roger / Schibli, Roger
Notes
Received 12 May 2016, Revised 7 June 2016, Accepted 7 June 2016, Published online 8 June 2016.More
Show all metadata